Showing results (131-140 of 154) with videos related to
Sort By:
Pageof 16
Acta Clinica Belgica|January 1, 1990
Comparison of anti-Helicobacter (Campylobacter) pylori IgG antibodies between different areas of BelgiumJ P Tomasi, G Bigaignon, M Delmée, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2010
A FRAX® model for the assessment of fracture probability in BelgiumH Johansson, J A Kanis, E V McCloskey, et al.Annals of the Rheumatic Diseases|October 30, 2007
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere, D Delferriere, C Roux, et al.Revue Medicale De Liege|February 11, 2010
[A FRAX model for the assessment of fracture probability in Belgium]A Neuprez, H Johansson, J A Kanis, et al.Clinical Orthopaedics and Related Research|April 1, 1987
New modes of administration of salmon calcitonin in Paget's disease. Nasal spray and suppositoryC Nagant de Deuxchaisnes, J P Devogelaer, J P Huaux, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2011
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux, D M Reid, J-P Devogelaer, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 10, 2014
Goal-directed treatment of osteoporosis in EuropeJ A Kanis, E McCloskey, J Branco, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type IN Loveridge, J A Fischer, C Nagant de Deuxchaisnes, et al.Rheumatology (Oxford, England)|February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective studyP Durez, F Van den Bosch, L Corluy, et al.Calcified Tissue International|May 28, 2004
Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's diseaseG Beyens, E Van Hul, K Van Driessche, et al.Pageof 16